AdaptHealth Closes $1.1B Credit Facility
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 13 2026
0mins
Should l Buy AHCO?
AdaptHealth announced that it has closed a $1.1B senior secured credit facility, consisting of a $325M Term Loan A, a $325M Delayed Draw Term Loan, and a $450M revolving line of credit. The closing of the Credit Facility follows recent rating upgrades by both S&P Global Ratings and Moody's Ratings, which recognized AdaptHealth's improved financial performance, strengthened balance sheet, and enhanced operating profile. The Company believes these upgrades, along with consistent free cash flow generation, directly contributed to the improved terms achieved in the new Credit Facility - including a meaningfully reduced pricing grid that reflects lender recognition of the Company's stronger credit standing. Proceeds from the new $325M Term Loan were used to fully repay, without penalty, the Company's existing Term Loan. The new $450M Revolver replaces the Company's existing $300M revolving credit facility, which had $100M drawn at the time the Credit Facility closed. The increased Revolver size provides enhanced liquidity to support the Company's ongoing operations. The $325M Delayed Draw Facility provides the Company with committed capital that may be drawn in up to two advances over a one-year availability period. Proceeds from the Delayed Draw Facility are intended to be used to redeem the Company's 6.125% Senior Notes due 2028, once they are callable at par in August 2026, lowering the Company's cost of debt.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AHCO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AHCO
Wall Street analysts forecast AHCO stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 12.710
Low
13.00
Averages
13.00
High
13.00
Current: 12.710
Low
13.00
Averages
13.00
High
13.00
About AHCO
AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Reinhart Partners Increases Stake in AdaptHealth by Nearly 2 Million Shares
- Share Accumulation: Reinhart Partners increased its stake in AdaptHealth by 1,981,198 shares during Q1 2026, with an estimated transaction value of $20.2 million, indicating growing confidence in the company and potentially boosting its stock performance.
- Increased Holdings Significance: Following this purchase, AdaptHealth now represents approximately 3.5% of Reinhart Partners' 13F reportable assets, highlighting the company's rising importance in the fund's portfolio and possibly attracting more institutional investor interest.
- Financial Performance: AdaptHealth reported revenue of $846.3 million in its latest earnings report, exceeding analyst expectations despite a roughly 1% year-over-year decline, while projecting net revenue of $3.44 billion to $3.51 billion for 2026, indicating potential business recovery.
- Enhanced Financing Capability: On April 13, AdaptHealth announced the closure of a $1.1 billion senior secured credit facility, reducing near-term refinancing risk and reflecting upgraded credit ratings, which bolsters market confidence in its future growth prospects.
See More
AdaptHealth Closes $1.1B Senior Secured Credit Facility
- Credit Facility Size: AdaptHealth announced the closure of a $1.1 billion senior secured credit facility, which includes a $325 million Term Loan A and a $450 million revolving credit, significantly enhancing the company's liquidity to support ongoing operations.
- Loan Utilization: The newly acquired $325 million term loan will be used to fully repay the existing term loan without penalty, optimizing the company's debt structure and reducing financing costs.
- Interest Rate Advantage: The new credit facility features a minimum interest rate reduced to 1.125% over SOFR, linked to the company's leverage ratio, which is expected to further lower financing costs during deleveraging, enhancing financial flexibility.
- Maturity Extension: The facility matures in April 2031, extending debt maturities by about two years, and is expected to lower the company's weighted average cost of debt by at least 25 basis points following the redemption of its 2028 senior notes, thereby strengthening the company's financial stability.
See More
Adobe CEO Resignation Triggers Stock Decline
- Adobe CEO Transition: Adobe's CEO Shantanu Narayen announced his resignation after a successor is named, causing shares to tumble over 5%, despite the company beating first-quarter earnings expectations, indicating market concerns over leadership changes.
- Fertilizer Stocks Retreat: Fertilizer companies' shares fell back due to ongoing disruptions in the Strait of Hormuz, with Intrepid Potash down about 8% and both Mosaic and CF Industries dropping around 4%, reflecting market sensitivity to raw material price fluctuations.
- Ulta Beauty Earnings Miss: Ulta Beauty reported fourth-quarter earnings of $8.01 per share, falling short of the $8.03 expected by analysts, leading to a 12% drop in stock price, despite revenue of $3.9 billion exceeding expectations, highlighting pressures on profitability.
- Once Upon A Farm Performance Decline: Once Upon A Farm reported its first earnings since going public, guiding for 2026 adjusted EBITDA of $2 million to $4 million, significantly lower than $6.6 million in Q4 2025, resulting in an 8% stock drop and raising concerns about future growth prospects.
See More
AdaptHealth and Kosmos Energy Insider Trading Analysis
- AdaptHealth Insider Purchase: On Thursday, Richard M. Cashin Jr. bought 2,046,691 shares of AHCO at $9.73 each, totaling $19.91 million, and is currently up about 7.5% based on today's trading high, indicating effective investment strategy.
- Stock Performance: AdaptHealth's stock rose approximately 4.9% on Friday, reflecting market optimism regarding its future growth and bolstering investor confidence.
- Kosmos Energy Insider Purchase: Director Adebayo O. Ogunlesi purchased 3,157,895 shares of KOS at $1.90 each on Tuesday, totaling $6 million, demonstrating his confidence in the company's prospects.
- Market Reaction: Kosmos Energy's stock increased about 1.1% on Friday, with Ogunlesi's investment up approximately 24.2% at the day's trading peak, indicating a positive market response to his buying activity.
See More
Halper Sadeh Investigates AdaptHealth Board Responsibilities
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers and directors of AdaptHealth Corp. breached their fiduciary duties to shareholders, potentially impacting corporate governance and shareholder rights.
- Legal Relief Options: Long-term shareholders of AdaptHealth stock may seek corporate governance reforms, fund recovery, or court-approved financial awards, which could directly affect the company's financial health and shareholder value.
- Importance of Participation: Shareholder involvement can improve a company's policies, practices, and oversight mechanisms, enhancing transparency and accountability, ultimately increasing shareholder value and reflecting effective corporate governance.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, demonstrating its influence in protecting investor rights.
See More
Wolverine World Wide Sees Surge in Options Trading Volume
- Surge in Options Volume: Wolverine World Wide (WWW) experienced an options trading volume of 11,306 contracts today, equating to approximately 1.1 million shares, which represents about 89.9% of its average daily trading volume over the past month, indicating strong market interest in its stock.
- High Put Option Activity: Notably, the $17.50 strike put option has seen significant trading, with 6,111 contracts exchanged today, representing around 611,100 shares, reflecting investor expectations of potential downward price movement.
- AdaptHealth Options Activity: Concurrently, AdaptHealth Corp (AHCO) also witnessed notable options trading, with a volume of 7,945 contracts, equivalent to approximately 794,500 shares, accounting for 82.8% of its average daily trading volume over the past month, highlighting active market engagement.
- Active Call Option Trading: The $10 strike call option for AHCO has been particularly active, with 7,847 contracts traded today, representing about 784,700 shares, suggesting a bullish sentiment among investors regarding its future stock price appreciation.
See More
Reinhart Partners Increases Stake in AdaptHealth by Nearly 2 Million Shares
- Share Accumulation: Reinhart Partners increased its stake in AdaptHealth by 1,981,198 shares during Q1 2026, with an estimated transaction value of $20.2 million, indicating growing confidence in the company and potentially boosting its stock performance.
- Increased Holdings Significance: Following this purchase, AdaptHealth now represents approximately 3.5% of Reinhart Partners' 13F reportable assets, highlighting the company's rising importance in the fund's portfolio and possibly attracting more institutional investor interest.
- Financial Performance: AdaptHealth reported revenue of $846.3 million in its latest earnings report, exceeding analyst expectations despite a roughly 1% year-over-year decline, while projecting net revenue of $3.44 billion to $3.51 billion for 2026, indicating potential business recovery.
- Enhanced Financing Capability: On April 13, AdaptHealth announced the closure of a $1.1 billion senior secured credit facility, reducing near-term refinancing risk and reflecting upgraded credit ratings, which bolsters market confidence in its future growth prospects.
See More
AdaptHealth Closes $1.1B Senior Secured Credit Facility
- Credit Facility Size: AdaptHealth announced the closure of a $1.1 billion senior secured credit facility, which includes a $325 million Term Loan A and a $450 million revolving credit, significantly enhancing the company's liquidity to support ongoing operations.
- Loan Utilization: The newly acquired $325 million term loan will be used to fully repay the existing term loan without penalty, optimizing the company's debt structure and reducing financing costs.
- Interest Rate Advantage: The new credit facility features a minimum interest rate reduced to 1.125% over SOFR, linked to the company's leverage ratio, which is expected to further lower financing costs during deleveraging, enhancing financial flexibility.
- Maturity Extension: The facility matures in April 2031, extending debt maturities by about two years, and is expected to lower the company's weighted average cost of debt by at least 25 basis points following the redemption of its 2028 senior notes, thereby strengthening the company's financial stability.
See More
Adobe CEO Resignation Triggers Stock Decline
- Adobe CEO Transition: Adobe's CEO Shantanu Narayen announced his resignation after a successor is named, causing shares to tumble over 5%, despite the company beating first-quarter earnings expectations, indicating market concerns over leadership changes.
- Fertilizer Stocks Retreat: Fertilizer companies' shares fell back due to ongoing disruptions in the Strait of Hormuz, with Intrepid Potash down about 8% and both Mosaic and CF Industries dropping around 4%, reflecting market sensitivity to raw material price fluctuations.
- Ulta Beauty Earnings Miss: Ulta Beauty reported fourth-quarter earnings of $8.01 per share, falling short of the $8.03 expected by analysts, leading to a 12% drop in stock price, despite revenue of $3.9 billion exceeding expectations, highlighting pressures on profitability.
- Once Upon A Farm Performance Decline: Once Upon A Farm reported its first earnings since going public, guiding for 2026 adjusted EBITDA of $2 million to $4 million, significantly lower than $6.6 million in Q4 2025, resulting in an 8% stock drop and raising concerns about future growth prospects.
See More
AdaptHealth and Kosmos Energy Insider Trading Analysis
- AdaptHealth Insider Purchase: On Thursday, Richard M. Cashin Jr. bought 2,046,691 shares of AHCO at $9.73 each, totaling $19.91 million, and is currently up about 7.5% based on today's trading high, indicating effective investment strategy.
- Stock Performance: AdaptHealth's stock rose approximately 4.9% on Friday, reflecting market optimism regarding its future growth and bolstering investor confidence.
- Kosmos Energy Insider Purchase: Director Adebayo O. Ogunlesi purchased 3,157,895 shares of KOS at $1.90 each on Tuesday, totaling $6 million, demonstrating his confidence in the company's prospects.
- Market Reaction: Kosmos Energy's stock increased about 1.1% on Friday, with Ogunlesi's investment up approximately 24.2% at the day's trading peak, indicating a positive market response to his buying activity.
See More
Halper Sadeh Investigates AdaptHealth Board Responsibilities
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers and directors of AdaptHealth Corp. breached their fiduciary duties to shareholders, potentially impacting corporate governance and shareholder rights.
- Legal Relief Options: Long-term shareholders of AdaptHealth stock may seek corporate governance reforms, fund recovery, or court-approved financial awards, which could directly affect the company's financial health and shareholder value.
- Importance of Participation: Shareholder involvement can improve a company's policies, practices, and oversight mechanisms, enhancing transparency and accountability, ultimately increasing shareholder value and reflecting effective corporate governance.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, demonstrating its influence in protecting investor rights.
See More
Wolverine World Wide Sees Surge in Options Trading Volume
- Surge in Options Volume: Wolverine World Wide (WWW) experienced an options trading volume of 11,306 contracts today, equating to approximately 1.1 million shares, which represents about 89.9% of its average daily trading volume over the past month, indicating strong market interest in its stock.
- High Put Option Activity: Notably, the $17.50 strike put option has seen significant trading, with 6,111 contracts exchanged today, representing around 611,100 shares, reflecting investor expectations of potential downward price movement.
- AdaptHealth Options Activity: Concurrently, AdaptHealth Corp (AHCO) also witnessed notable options trading, with a volume of 7,945 contracts, equivalent to approximately 794,500 shares, accounting for 82.8% of its average daily trading volume over the past month, highlighting active market engagement.
- Active Call Option Trading: The $10 strike call option for AHCO has been particularly active, with 7,847 contracts traded today, representing about 784,700 shares, suggesting a bullish sentiment among investors regarding its future stock price appreciation.
See More
